Patents Assigned to EVANESC THERAPEUTICS, INC.
  • Patent number: 11911098
    Abstract: Current cancer treatments such as surgery, radiation and chemotherapy have significant side-effects for the patients. New treatments are being developed to reduce these side-effects while giving doctors alternative methods to treat patients. This invention introduces a new apparatus for treatment of malignant tumors including brain cancer, pancreatic cancer, lung cancer, ovarian cancer, and breast cancer. The apparatus couples RF power into the tumor using evanescent waves. The evanescent waves disrupt the division of cancer cells causing the cancer cells to die and shrink the size of the tumor. Due to the targeted approach of the evanescent waves, less RF energy is wasted in healthy cells.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: February 27, 2024
    Assignee: Evanesc Therapeutics, Inc.
    Inventors: Mehran Matloubian, Timothy J. Brockett, Gregg A. Hollingsworth
  • Patent number: 11213349
    Abstract: Current cancer treatments such as surgery, radiation and chemotherapy have significant side-effects for the patients. New treatments are being developed to reduce these side-effects while giving doctors alternative methods to treat patients. This invention introduces a new apparatus for treatment of malignant tumors including brain cancer, pancreatic cancer, lung cancer, ovarian cancer, and breast cancer. The apparatus couples RF power into the tumor using evanescent waves. The evanescent waves disrupt the division of cancer cells causing the cancer cells to die and shrink the size of the tumor. Due to the targeted approach of the evanescent waves, less RF energy is wasted in healthy cells.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: January 4, 2022
    Assignee: EVANESC THERAPEUTICS, INC.
    Inventors: Mehran Matloubian, Timothy J. Brockett, Gregg A. Hollingsworth
  • Patent number: 11058886
    Abstract: Current cancer treatments such as surgery, radiation and chemotherapy have significant side-effects for the patients. New treatments are being developed to reduce these side-effects while giving doctors alternative methods to treat patients. This invention introduces a new method for treatment of malignant tumors including brain cancer, pancreatic cancer, lung cancer, and ovarian cancer. The method uses low-power RF wave to disrupt and kill cancer cells during mitosis resulting in shrinking the size of solid tumors. Direction of polarization of the electric field of the RF wave relative to the axis of division of the cancer cells has an impact on the ability of the RF wave in disrupting mitosis and killing the cancer cells. Since the orientation of the cancer cells in a tumor are random a method is needed to change the orientation of the applied RF wave spatially with time to maximize elimination of the cancer cells.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 13, 2021
    Assignee: EVANESC THERAPEUTICS, INC.
    Inventors: Mehran Matloubian, Timothy J. Brockett, Gregg A. Hollingsworth